# Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

> **NCT01607086** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DRUG:** Cherry lamotrigine ODT
- **DRUG:** Cherry Placebo

## Key facts

- **NCT ID:** NCT01607086
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-11
- **Primary completion:** 2008-07-18
- **Final completion:** 2008-07-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607086, "Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01607086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*